Suppression of pro-inflammatory IL-1 family members and IL-6 has been shown to have a therapeutic effect in many inflammatory diseases, including viral infections, and has been explored as a potential therapeutic avenue in COVID-19 [44]. Here, IL6 is linked to viral infectious disease.